Anne M. Stevens
Affiliations: | University of Washington, Seattle, Seattle, WA |
Area:
Pediatric RheumatologyGoogle:
"Anne Stevens"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Stevens AM, Torok KS, Li SC, et al. (2019) Immunopathogenesis of Juvenile Systemic Sclerosis. Frontiers in Immunology. 10: 1352 |
Torok KS, Li SC, Jacobe HM, et al. (2019) Immunopathogenesis of Pediatric Localized Scleroderma. Frontiers in Immunology. 10: 908 |
Patel Z, Lu X, Miller D, et al. (2018) A plausibly causal functional lupus-associated risk variant in the STAT1-STAT4 locus. Human Molecular Genetics |
Stevens BE, Torok KS, Li SC, et al. (2018) Clinical characteristics and factors associated with disability and impaired quality of life in children with juvenile systemic sclerosis. Arthritis Care & Research |
Hinkle A, Yuasa M, Peckham D, et al. (2018) AI-01 Kv1.3 expression on systemic lupus erythematosus (SLE) urinary leukocytes Lupus Science & Medicine. 5 |
Foeldvari I, Klotsche J, Kasapcopur O, et al. (2018) THU0577 Do raynaud phenomenon negative juvenile systemic scleroderma patients have a different pattern of organ involvement as raynaud phenomenon positive patients Annals of the Rheumatic Diseases. 77: 490-490 |
Hamada S, Caballero-Benitez A, Duran KL, et al. (2017) Soluble MICB in Plasma and Urine Explains Population Expansions of NKG2D(+)CD4 T Cells Inpatients with Juvenile-Onset Systemic Lupus Erythematosus. Open Journal of Immunology. 7: 1-17 |
Yu J, Brandling-Bennett H, Co DO, et al. (2016) Toxic Epidermal Necrolysis-Like Cutaneous Lupus in Pediatric Patients: A Case Series and Review. Pediatrics |
Stevens AM, Kanaan SB, Torok KS, et al. (2016) HLA DRB1, DQA1 and DQB1 in Juvenile Onset Systemic Sclerosis. Arthritis & Rheumatology (Hoboken, N.J.) |
Deng Y, Zhao J, Sakurai D, et al. (2016) Decreased SMG7 expression associates with lupus-risk variants and elevated antinuclear antibody production. Annals of the Rheumatic Diseases |